Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Post by hvaron Jul 28, 2011 1:01pm
549 Views
Post# 18883681

Northern Financial Initiates Coverage on Golden Pr

Northern Financial Initiates Coverage on Golden PrNorthern Financial Announces its Wholly-Owned Subsidiary, Northern Securities Inc., Initiates Coverage on Golden Predator Corp.20 hours ago by CNW Group
(TSX: NFC)
Northern Financial Corporation is pleased to announce that its wholly-owned subsidiary, Northern Securities Inc. ("Northern Securities"), has initiated research coverage on Golden Predator Corp. (TSX: GPD) with a Speculative Buy rating and a 12-month target price of $1.60.
Analyst Kwong-Mun Achong Low provides a comprehensive research report on the company and its extensive exploration properties in the Yukon Territory. Golden Predator is the largest holder of exploration property in the Yukon and is focused on exploring for gold on a number of properties, with emphasis on the Brewery Creek asset, a former producing mine. The company also has a royalty portfolio in Nevada, one of which currently receives royalty payments from operator Barrick Gold.
As Canada's Small Cap Investment Bank with a focus on mining, technology and special situations, Northern Securities is committed to providing insightful research coverage of compelling Canadian companies.
About Northern Financial Corporation
Northern Financial Corporation wholly owns Northern Securities Inc., a full service investment dealer that provides financial advisory services to retail and institutional clients and investment banking services to small capitalization companies.
The Toronto Stock Exchange does not accept responsibility for the adequacy or accuracy of this news release. This press release may contain forward-looking statements with respect to the Company, its operations, strategy, financial performance and condition. These statements generally can be identified by use of forward looking words such as "may", "will", "expect", "estimate", "anticipate", intends", "believe" or "continue" or the negative thereof or similar variations. The actual results and performance of the Company discussed herein could differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, changes in government regulations and the factors described under "Risk Factors" in the Management's Discussion and Analysis and Filing Statement of the Company which are available at www.sedar.com. The cautionary statements qualify all forward-looking statements attributable to the Company and persons acting on their behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release and the Company has no obligation to update such statements.
To view this news release in HTML formatting, please use the following URL: https://www.newswire.ca/en/releases/archive/July2011/27/c7905.html
SOURCE: Northern Financial Corporation
Vic Alboini Chairman &Chief Executive Officer (416) 644-8110
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse